Factor V Deficiency
Understanding Factor V Deficiency (Parahemophilia, Owren's Disease): Find information on diagnosis, clinical features, and medical coding for Factor V deficiency. This resource covers healthcare considerations, laboratory testing, and treatment options for patients with inherited bleeding disorders. Learn about Factor V Leiden mutation testing, differential diagnosis, and ICD-10 codes related to Factor V deficiency for accurate clinical documentation and billing.
Inherited bleeding disorder due to reduced Factor V activity, impairing blood clot formation.
Easy bruising, prolonged bleeding from cuts or injuries, heavy menstrual periods, nosebleeds.
Diagnosed via blood tests (factor V activity assay) in hematology clinics or hospitals after bleeding events.
ICD-10 Code Families
Complete code families applicable to D68.21
When to use each related code
| Description | When to use |
|---|---|
| Blood doesn't clot normally, causing easy bleeding. | Factor V deficiency confirmed by lab tests. Consider for unexplained bleeding or family history. |
| Combined deficiency of factors V and VIII, rare bleeding disorder. | Suspect when bleeding symptoms present and both Factor V and VIII levels are low. Genetic testing recommended. |
| Blood clots too easily, increased risk of DVT and PE. | Do NOT use for Factor V deficiency. Use for Factor V Leiden mutation, confirmed by genetic testing. Consider with recurrent clots. |
Best-practice checklist
- ✓Factor V deficiency diagnosis: Document prolonged PT/PTT.
- ✓Factor V assay: Include specific activity level.
- ✓Bleeding history: Detail type, frequency, and severity.
- ✓Family history of bleeding disorders: Document if present.
- ✓Rule out other coagulopathies: Document differential diagnosis.
Common pitfalls to avoid
Coding F5 deficiency without specifying acquired vs. hereditary (e.g., F5 Leiden) impacts severity and treatment.
Discrepancies between clinical notes and coded diagnosis (e.g., parahemophilia vs. Owren's) can lead to audit issues.
Failing to code related manifestations (e.g., DVT, pulmonary embolism) underreports disease severity and resource utilization.
Best-practice tips
- 01Document family history of Factor V Leiden mutation for accurate risk assessment.
- 02Ensure appropriate ICD-10-CM coding (D68.59) for Factor V deficiency.
- 03Monitor patients for bleeding complications and administer fresh frozen plasma (FFP) as needed.
- 04Advise patients on avoiding aspirin and NSAIDs to minimize bleeding risk.
- 05Implement genetic testing and counseling for at-risk family members.
Step-by-step checklist
- 1
Verify prolonged PT/PTT, normal bleeding time.
- 2
Check Factor V assay <5-30% normal.
- 3
Exclude other bleeding disorders.
- 4
Consider family history of bleeding.
- 5
Document F5 gene mutation if tested.
Ready-to-paste narrative
Patient presents with [chief complaint related to bleeding e.g., easy bruising, prolonged bleeding after minor injury, epistaxis, menorrhagia]. Review of systems reveals [positive findings related to bleeding or family history, e.g., hematuria, gingival bleeding, family history of bleeding disorder]. Physical exam findings include [relevant findings e.g., ecchymoses, petechiae, active bleeding]. Given the clinical presentation, Factor V deficiency, also known as parahemophilia or Owren's disease, is suspected. Differential diagnosis includes other inherited bleeding disorders such as hemophilia A, hemophilia B, von Willebrand disease, and other coagulation factor deficiencies. Coagulation studies including Factor V assay were ordered to confirm the diagnosis and assess the severity of the deficiency. Preliminary laboratory results indicate [initial findings, e.g., prolonged PT, normal aPTT]. Further testing may include genetic testing for Factor V Leiden mutation to differentiate from activated protein C resistance. Diagnosis of Factor V deficiency will be confirmed based on reduced Factor V activity levels. Management plan will be determined based on the severity of the deficiency and bleeding manifestations. Treatment options for acute bleeding episodes may include fresh frozen plasma, Factor V concentrate, or recombinant Factor V. Prophylactic treatment may be considered in patients with a history of severe bleeding. Patient education on bleeding precautions, signs and symptoms of bleeding, and the importance of regular follow-up with a hematologist will be provided. ICD-10 code D68.4 (Factor V deficiency) is documented. Follow-up appointment scheduled for [date] to discuss complete coagulation panel results and establish a long-term management plan.
Common questions and answers
What are the most effective diagnostic strategies for confirming Factor V Leiden and differentiating it from inherited Factor V deficiency?+
Differentiating Factor V Leiden, a genetic mutation causing activated protein C resistance, from inherited Factor V deficiency, a bleeding disorder, requires a multi-pronged approach. While both affect Factor V, their clinical presentations differ significantly. Begin with a thorough patient history, including family history of bleeding or thrombotic events. Prolonged activated partial thromboplastin time (aPTT) and prothrombin time (PT) can suggest Factor V deficiency, but are usually normal in Factor V Leiden. A key diagnostic test is the Factor V activity assay. Low levels confirm Factor V deficiency, while normal or near-normal levels suggest Factor V Leiden or other causes. Genetic testing for the Factor V Leiden mutation can definitively confirm that diagnosis. Consider implementing a stepwise diagnostic algorithm starting with coagulation screening, followed by Factor V activity assay, and finally genetic testing to provide accurate diagnosis and guide appropriate management. Explore how specific laboratory assays can help pinpoint the underlying cause of coagulopathy.
How does managing acute bleeding episodes in a patient with known Factor V deficiency differ from standard hemophilia A or B management?+
Managing acute bleeding in Factor V deficiency differs from hemophilia A or B, primarily in the choice of replacement therapy. Unlike hemophilia, where factor VIII or IX concentrates are used, Factor V deficiency requires fresh frozen plasma (FFP) or, ideally, a purified Factor V concentrate if available. FFP contains all coagulation factors, effectively replenishing Factor V. The dose and frequency of FFP depend on the severity and location of the bleeding. While recombinant Factor V concentrates are not widely accessible, they offer advantages over FFP, including reduced risk of volume overload and infectious disease transmission. Consider implementing a treatment protocol based on patient-specific factors like bleeding severity and access to specialized therapies. Learn more about the optimal utilization of FFP and the potential benefits of Factor V concentrates in managing acute bleeding episodes.
Beyond FFP, what other treatment strategies should clinicians consider for long-term management of Factor V deficiency and preventing future bleeding complications?+
Long-term management of Factor V deficiency requires a proactive approach to minimize bleeding risks and improve quality of life. While FFP is crucial for acute bleeding, regular prophylactic FFP infusions are generally not recommended due to potential complications. Patient education on recognizing early bleeding signs and promptly seeking medical attention is essential. Desmopressin (DDAVP), although less effective than in other bleeding disorders, may be considered for minor bleeding or as a pre-operative measure in some individuals. Antifibrinolytics like tranexamic acid can also be used as adjunctive therapy for mucosal bleeding. Explore how a multidisciplinary approach involving hematologists, genetic counselors, and other specialists can improve patient outcomes and reduce long-term morbidity associated with Factor V deficiency.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.